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ABSTRACT
ObjeCtives
To examine the prospective associations between 
consumption of sugar sweetened beverages, 
artificially sweetened beverages, and fruit juice with 
type 2 diabetes before and after adjustment for 
adiposity, and to estimate the population attributable 
fraction for type 2 diabetes from consumption of sugar 
sweetened beverages in the United States and United 
Kingdom.
Design
Systematic review and meta-analysis.
Data sOurCes anD eligibility
PubMed, Embase, Ovid, and Web of Knowledge for 
prospective studies of adults without diabetes, 
published until February 2014. The population 
attributable fraction was estimated in national surveys 
in the USA, 2009-10 (n=4729 representing 189.1 
million adults without diabetes) and the UK, 2008-12 
(n=1932 representing 44.7 million).
synthesis methODs
Random effects meta-analysis and survey analysis for 
population attributable fraction associated with 
consumption of sugar sweetened beverages.
results
Prespecified information was extracted from 17 
cohorts (38 253 cases/10 126 754 person years). 
Higher consumption of sugar sweetened beverages 
was associated with a greater incidence of type 2 
diabetes, by 18% per one serving/day (95% 
confidence interval 9% to 28%, I2 for 
heterogeneity=89%) and 13% (6% to 21%, I2=79%) 
before and after adjustment for adiposity; for 
artificially sweetened beverages, 25% (18% to 33%, 
I2=70%) and 8% (2% to 15%, I2=64%); and for fruit 
juice, 5% (−1% to 11%, I2=58%) and 7% (1% to 14%, 
I2=51%). Potential sources of heterogeneity or bias 
were not evident for sugar sweetened beverages. 
For artificially sweetened beverages, publication 
bias and residual confounding were indicated. For 
fruit juice the finding was non-significant in studies 
ascertaining type 2 diabetes objectively (P for 
heterogeneity=0.008). Under specified 
assumptions for population attributable fraction, of 
20.9 million events of type 2 diabetes predicted to 
occur over 10 years in the USA (absolute event rate 
11.0%), 1.8 million would be attributable to 
consumption of sugar sweetened beverages 
(population attributable fraction 8.7%, 95% 
confidence interval 3.9% to 12.9%); and of 2.6 
million events in the UK (absolute event rate 5.8%), 
79 000 would be attributable to consumption of 
sugar sweetened beverages (population 
attributable fraction 3.6%, 1.7% to 5.6%).
COnClusiOns
Habitual consumption of sugar sweetened beverages 
was associated with a greater incidence of type 2 
diabetes, independently of adiposity. Although 
artificially sweetened beverages and fruit juice also 
showd positive associations with incidence of type 2 
diabetes, the findings were likely to involve bias. None 
the less, both artificially sweetened beverages and 
fruit juice were unlikely to be healthy alternatives to 
sugar sweetened beverages for the prevention of type 
2 diabetes. Under assumption of causality, 
consumption of sugar sweetened beverages over years 
may be related to a substantial number of cases of 
new onset diabetes.
Introduction
The health effects of sugar sweetened beverages, artifi-
cially sweetened beverages, and fruit juice have 
received considerable attention from scientific and 
public communities. The consumption of sugar sweet-
ened beverages is likely to contribute to an increase in 
obesity and the development of type 2 diabetes.1-5  Arti-
ficially sweetened beverages and fruit juice are candi-
date alternatives to sugar sweetened beverages, but 
their prospective associations with type 2 diabetes have 
WhAT IS AlReAdy knoWn on ThIS TopIC
Current evidence is limited to answer whether or not consumption of sugar 
sweetened beverages, artificially sweetened beverages, and fruit juice is 
associated with risk of diabetes after adjustment for obesity status
Despite in the debate of a policy intervention to reduce consumption of sugar 
sweetened beverages, no study has estimated how many incident cases of diabetes 
may be caused by consuming sugar sweetened beverages
WhAT ThIS STudy AddS
Habitual consumption of sugar sweetened beverages was positively associated 
with incidence of type 2 diabetes, independently of obesity status
Under an assumption of causality, consumption of sugar sweetened beverages may 
be linked to 4-13% of type 2 diabetes incidence in the United States and 2-6% in the 
United Kingdom over 10 years, 2010-20
Artificially sweetened beverages and fruit juice were both positively associated with 
incident type 2 diabetes, but likely to involve bias, and seemed not to be healthy 
options for the prevention of type 2 diabetes
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not yet been well established because only a few  studies 
have examined the associations, of which potential bias 
has been debated.5-9
Each of these beverage types has been investigated 
and reviewed for prospective associations with inci-
dent type 2 diabetes.4-9  A few quantitative reviews were 
available, but one aggregated studies that did and did 
not adjust for obesity status4 9  and the other separated 
such studies ad hoc only for those of sugar sweetened 
beverages and not for those of artificially sweetened 
beveraor fruit juice.5  It is crucial to better characterise 
the influence of adiposity because obesity can directly 
cause type 2 diabetes and thus mediate an association 
between consumption of sugar sweetened beverages 
and type 2 diabetes;4 5  and because obesity can be a 
confounder by altering dietary habits and confounding 
an association between beverage consumption and 
incident type 2 diabetes.8 10  Previous studies indeed 
reported that obese individuals tend to consume more 
sugar sweetened and artificially sweetened beverages 
and less fruit juice than leaner individuals.6 10 11  More-
over, despite the growing interest in a policy interven-
tion to reduce the consumption of sugar sweetened 
beverages at a population level,12 13 14 no study has 
translated a prospective association between con-
sumption of sugar sweetened beverages and type 2 dia-
betes into a measure of its population level impact, 
including population attributable fraction, in a con-
temporary population.
We therefore conducted a systematic review and 
meta-analysis of prospective studies to test whether or 
not habitual consumption of sugar sweetened bever-
ages, artificially sweetened beverages, or fruit juice 
would be associated with the incidence of type 2 diabe-
tes. We specifically aimed to meta-analyse the associa-
tions with and without adjustment for adiposity, 
because the association may be both mediated and con-
founded by this factor. To provide policy relevant mea-
sures, we then used the result of the meta-analysis for 
sugar sweetened beverages to estimate the population 
attributable fraction for the 10 year risk of developing 
type 2 diabetes due to consumption of sugar sweetened 
beverages in contemporary populations of the United 
States and United Kingdom, where approximately half 
of each population in recent years consumed sugar 
sweetened beverages.1 10
Methods
Patient involvement
There was no patient involvement in this study.
study searches and selection
Following the PRISMA guidelines15  and the protocol 
(not registered, available on request), we identified 
relevant studies through hand searches and system-
atic searches of four databases on 31 May 2013 
(updated on 10 February 2014): PubMed, Embase, 
Ovid, and Web of Knowledge. Search terms included 
those related to types of beverages, diabetes, and pro-
spective study design (see supplementary information 
for details). Time and language of publications were 
not restricted. After the removal of duplicates, one 
author (FI) screened the articles on the basis of the 
titles and abstracts and three authors (FI, LO’C, and 
ZY) independently reviewed them in duplicate. We 
considered studies to be eligible for inclusion if they 
were of a prospective design, assessed the consump-
tion of beverages and incident type 2 diabetes, and 
recruited adults free of diabetes and aged 18 years or 
older. We also considered a follow-up of at least two 
years on average because incidence of diabetes could 
alter approximately two years after modification of 
lifestyle.16 17
Data extraction and quality assessment
We extracted information in a standardised manner in 
duplicate, including baseline personal information 
such as body mass index, and duration of follow-up, 
exclusion criteria, sample size, loss to follow-up, 
assessments of beverage consumption and incident 
type 2 diabetes, types of beverage consumed, measures 
of prospective associations with 95% confidence inter-
vals, covariates evaluated, and sources of funding. We 
extracted measures of associations that were the most 
adjusted for sociodemographic and lifestyle factors, 
with and without further adjustment for adiposity mea-
sures. Although adjustment for total energy intake is 
important to assess,4 6 in this meta-analysis we used 
estimates adjusted for total energy whenever possible 
for parsimony and potentials for energy adjustment to 
reduce confounding and measurement errors.18 We 
extracted estimates stratified by age, sex, and adiposity 
measures, if reported, to use in meta-regression to 
assess heterogeneity. Additional information on study 
design and quality was also obtained from identified 
articles as well as from relevant articles of identified 
cohorts.
We contacted authors of identified articles to request 
additional information if the article did not report two 
types of estimates before and after adjustment for adi-
posity, based on either categorical or continuous analy-
sis for sugar sweetened beverages, artificially sweetened 
beverages, and fruit juice separately. When we con-
tacted authors we requested estimates before and after 
adjustment for adiposity based on both continuous and 
categorical variables of each beverage consumed, and 
we requested estimates based on longer follow-up if 
available. In addition we contacted authors of cohorts 
that did not meet eligibility criteria but could be eligible 
on the provision of additional information (see supple-
mentary table S1).
We examined risks of bias in concordance with the 
Cochrane tools, including a Cochrane risk of bias 
assessment tool for non-randomised studies of inter-
ventions.19-21  Seven domains were assessed: con-
founding, selection, exposure measurement, 
misclassification over time, missing data, outcome 
measurement, and selective reporting. Bias specific to 
this meta-analysis included the likelihood of misclas-
sifying sugar sweetened fruit drink as fruit juice (for 
example, fruit punch). Sources of bias were evaluated 
by using meta-regression for each as a potential 
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source of heterogeneity, meta-analysis excluding 
studies with a certain type of bias, or meta-analysis 
incorporating quantitative measures of bias (see sup-
plementary information). Overall quality of evidence 
was assessed based on study quality, results from sen-
sitivity analysis, and principles of the grades of rec-
ommendation, assessment, development, and 
evaluation (GRADE).22 One author (FI) first sum-
marised the results of bias assessment and quality of 
overall evidence and these results were discussed 
among the other authors (FI, LOC, YZ, and NGF) for 
consensus.
meta-analysis
We used Stata 13.1 for analyses (α two sided P=0.05, 
unless indicated). Statistical details are described in the 
supplementary information. Each of sugar sweetened 
beverages, artificially sweetened beverages, and fruit 
juice was considered as the main exposure. We defined 
sugar sweetened beverages as any sweetened bever-
ages, including sugar sweetened fruit juice, not pre-
sented as diet or non-caloric beverages. Artificially 
sweetened beverages included low caloric soft drinks as 
reported in each study. Fruit juice was defined as 100% 
fruit juice, or fruit juice assessed separately from fruit 
drinks. We standardised measures of associations to 
relative risk per one serving/day of beverage consump-
tion, after we confirmed that this unit was the most fre-
quently used in studies. Because volume per serving 
was specific to a population, ranging from 237 mL (one 
cup) to 355 mL (12 oz) (median across publications=250 
mL/day), we repeated meta-analysis to estimate the rel-
ative risk for each 250 mL/day. We converted odds 
ratios, if reported, to relative risks.23  If a study reported 
categorical estimates only, they were combined to 
obtain a single dose-response estimate.24 If only strati-
fied estimates were reported, we merged them by fixed 
effects meta-analysis to derive a cohort specific esti-
mate, assuming consistency of associations within a 
cohort.
We performed random effects meta-analysis as pre-
specified, assuming that biological effects of bever-
ages in different populations would vary randomly at 
least by processing and composition of beverages. 
The heterogeneity of associations was expressed by 
I2.25  For each of the beverages of interest, we esti-
mated relative risks before and after adjustment for 
adiposity measures. To assess a magnitude of overall 
confounding, we additionally estimated crude rela-
tive risks without any adjustment. Non-linear associ-
ations were additionally evaluated by cubic spline 
meta-analysis for which we used available categorical 
estimates.24
In observational studies, within person variability 
of exposure can cause bias.26-30  As performed previ-
ously,26-32  we compiled within person variation of bev-
erage consumption in each study and adjusted for 
them to estimates of each study. Uncertainty in self 
reported diagnosis of type 2 diabetes was also cali-
brated for estimates from studies without objective 
information on incidence of type 2 diabetes.33 To compute 
relative risks adjusted for within person dietary vari-
ation and uncertainty of type 2 diabetes ascertain-
ment, we pooled the estimates after study specific 
 calibration.
Meta-regression was used to assess if heterogeneity 
of associations across studies depended on population 
demographics, study characteristics, and indicators of 
errors or bias. Publication status (peer reviewed or not), 
selective reporting (yes or no), and mutual adjustment 
for three beverage types were evaluated after we identi-
fied studies with those characteristics. Stratified 
meta-analysis was performed by each variable that pre-
dicted heterogeneity (P<0.01) and by prespecified vari-
ables: age, sex, body mass index, and study location. In 
exploratory analysis using multiple variables of study 
specific factors, we reassessed I2 as a magnitude of 
unexplained heterogeneity.
Publication bias was assessed by Egger’s test, with a 
contour enhanced funnel plot, and ‘trim and fill’ analy-
sis.34  If publication bias was indicated, we adjusted 
summary estimates for the bias.34  Robustness of sum-
mary findings was examined by sensitivity analyses: 
influence analysis,32  fixed effects meta-analysis, analy-
sis using millilitres per day as a unit, analysis without 
studies with a high overall risk of bias, and analysis 
incorporating measures of uncertainty in adjustment 
for within person dietary variations and diagnosis of 
type 2 diabetes.35
Adiposity is likely to confound an association of 
beverage consumption with type 2 diabetes, particu-
larly in research on artificially sweetened bever-
ages.6 8 10 11  Because of imperfect measurement of 
adiposity in an epidemiological study,36  adjustment 
for adiposity was likely to be insufficient, as discussed 
previously.3 6 32 37-41  Thus, to assess if such residual con-
founding would be substantial, we performed simula-
tion analysis to examine the influence of the bias.42
type 2 diabetes risk attributable to sugar 
sweetened beverages in usa and uK
We estimated the risks of type 2 diabetes attributable to 
consumption of sugar sweetened beverages over 10 
years in the USA and UK.43 44  These countries contrib-
uted to the meta-analysis to the largest extent and pro-
vided publically available data on diets and risk factors 
for type 2 diabetes: the US national health and nutri-
tion examination survey, 2009-1045  and the UK national 
diet and nutrition survey, 2008-12.46 The recent cycle 
was selected for greater generalisability to recent pop-
ulations. Selecting adults aged 20 years or more and 
without prevalent diabetes, we analysed 4729 US 
adults and 1932 UK adults. Accounting for sampling 
weight, 189.1 million US adults and 44.7 million UK 
adults were represented.
We estimated the population attributable fraction by 
applying a Cochrane Collaboration algorithm to survey 
data.43 44  We first estimated habitual consumption of 
sugar sweetened beverages based on 24 hour recalls in 
the USA and four day food records in the UK. Then we 
estimated the 10 year risk of type 2 diabetes based on a 
risk prediction algorithm developed and validated in 
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each country.47  48  The predicted risk for each individ-
ual was considered as an “assumed control risk”44  if 
the current consumption of sugar sweetened bever-
ages would remain constant. Then we calculated an 
 alternative risk if the consumption of sugar sweetened 
beverages would become zero, calculating assumed 
control risk×(1/relative risk per serving/day)×observed 
sugar sweetened beverages servings/day. The differ-
ence between the two risk estimates represented a risk 
attributable to consumption of sugar sweetened bever-
ages. Using the risk estimates, sampling weights, and 
a population size, we estimated the absolute numbers 
of events over 10 years, events attributable to con-
sumption of sugar sweetened beverages (absolute risk 
reduction44), and population attributable fraction (the 
proportion of events attributable to consumption of 
sugar sweetened beverages). The estimation assumed 
causality and no change in individuals’ characteris-
tics over time. Validation of 10 year risk prediction 
was performed in the US survey, in which we pre-
dicted diabetes prevalence in 2009-10 by using data 
collected in 1999-2000. Sensitivity analysis was per-
formed to estimate the population attributable frac-
tion by varying relative risks and accounting for 
uncertainty. Further details are presented in the sup-
plementary  information.
Results
After the removal of duplicates, we identified 1937 arti-
cles, reviewed 33 in full text, and identified 21 articles of 
16 cohorts as being eligible for this meta-analysis (see 
supplementary figure S1). We obtained unpublished 
information on one cohort from a publication that did 
not meet eligibility criteria (see supplementary table 
S1).22  Finally, we evaluated data from 17 cohorts 
(table 1 )11  39-41 49-65 comprising 38 253 cases of type 2 dia-
betes over 10 126 756 person years in total. No study or 
publication was funded by industry.
The quality of the studies has been examined (see 
supplementary table S2). Methods of assessing diets 
and ascertaining type 2 diabetes and validity of these 
measurements varied across studies (table 1 and sup-
plementary table S3). We identified potential bias in 
the quantitative results for six cohorts based on at 
least one of the following: publication of a conference 
abstract only,62  exclusion of participants lost during 
follow-up,57  63  likelihood of substantial residual con-
founding,40  and no separation between fruit juice 
and sugar sweetened beverages (fruit drinks) or 
between sugar sweetened beverages and artificially 
sweetened beverages.57 64  Selective reporting might 
exist in some studies,39  52  55  58  62 64  but it was unlikely 
to cause bias—for example, reporting only non-quan-
titative results for sugar sweetened beverages in a 
study mainly on artificially sweetened beverages.39 
Other potential sources of bias were detected, but we 
did not consider them to be substantially influential 
on overall bias in each study, partly based on results 
of sensitivity analyses. No study assessed subtypes of 
sugar sweetened beverages, artificially sweetened 
beverages, or fruit juice, except one that separated 
beverages by caffeine content.49
Confounding was likely to exist in all of the studies. 
As would be expected, consumers of artificially sweet-
ened beverages tended to be overweight or obese or 
hypertensive.11 39 50 59 66  In longitudinal analysis, all 
studies statistically adjusted for potential confounders, 
such as sociodemographic variables, clinical factors 
(family history of diabetes or prevalent diseases), and 
lifestyle factors, including diet (see supplementary 
table S4). None of these factors was identified as a 
 single cause of confounding, according to studies 
assessing influence of potential confounding in differ-
ent regression models.11 41 49-51 54 59 61 63-65  However, a com-
bination of multiple factors was likely to cause 
confounding (table 2 and supplementary table S4). 
After adjustment for multiple potential confounders, 
the relative risk for sugar sweetened beverages was 
attenuated from 1.25 to 1.18 (32% change), and for artifi-
cially sweetened beverages from 1.48 to 1.25 (43%). By 
contrast, the point estimate for fruit juice was shifted 
upwards, from 0.97 to 1.05.
beverage consumption and type 2 diabetes
Table 2 summarises the findings from meta-analysis. 
Higher consumption of sugar sweetened beverages by 
one serving per day was associated with an 18% greater 
incidence of type 2 diabetes (95% confidence interval 
8.8% to 28%; I2=89%) before adjustment for adiposity 
(fig 1 and table 2). When adjusted for potential media-
tion and confounding by adiposity, the association was 
attenuated, with the incidence increased by 13% per 
serving/day (5.8% to 21%; I2=79%). In the analysis of 
artificially sweetened beverages, in which adiposity 
was unlikely to be a mediator, higher consumption of 
artificially sweetened beverages by one serving per day 
was associated with a 25% greater incidence of type 2 
diabetes (95% confidence interval 18% to 33%; I2=70%) 
before adjustment for adiposity. After adjustment, the 
estimate of 25% greater incidence was attenuated to 8% 
(2.1% to 15%).
In the analysis of fruit juice, the influence of adjust-
ment for adiposity was in the direction opposite to that 
of the analysis for sugar sweetened beverages and arti-
ficially sweetened beverages. The association of fruit 
juice consumption with incident type 2 diabetes was 
strengthened after adjustment for adiposity measures. 
Higher consumption of fruit juice by one serving/day 
was associated with a 7% greater incidence of type 2 
diabetes (95% confidence interval 0.8% to 14%).
Each of the beverages showed significant non-linear 
associations (P>0.05) (supplementary figure S2). Cali-
bration for within person variation strengthened the 
association between each type of beverage and incident 
type 2 diabetes (fig 1 and table 2). For example, the rela-
tive risk per one serving/day of sugar sweetened bever-
ages was strengthened, from 1.13 (95% confidence 
interval 1.06 to 1.21) to 1.28 (1.12 to 1.46). Estimates for 
artificially sweetened beverages were strengthened 
similarly. The influence was small for fruit juice, where 
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the relative risk was shifted only slightly, from 1.07 (1.01 
to 1.14) to 1.10 (1.01 to 1.20).
sensitivity analysis and quality of evidence
None of the study specific factors evaluated could 
explain heterogeneity of results for sugar sweetened 
beverages and artificially sweetened beverages (P>0.1) 
(see supplementary table S5). Exploratory meta- 
regression produced an I2 of 23.4% for sugar sweet-
ened beverages and of 67.8% for artificially sweetened 
beverages, adjusted for population demographics 
(age, sex, country, incidence), body mass index, fol-
low-up duration, and measures of study quality. The 
results for fruit juice varied by study design. While 
studies assessing self reported type 2 diabetes only 
showed a positive association, the significant associa-
tion disappeared in studies ascertaining the incidence 
of type 2 diabetes by medical records or by blood glu-
cose or glycated haemoglobin level (relative risk 1.08, 
0.97 to 1.20; P for heterogeneity=0.008). Additionally, 
studies with repeated measures of diets supported a 
null finding (0.98, 0.86 to 1.11; P for heterogene-
ity=0.068). These factors of study design explained 
heterogeneity of the association, reducing I2 from 29% 
to 0%. Demographic variables and body mass index 
did not explain heterogeneity (P>0.14 each), whereas 
sugar sweetened beverages, artificially sweetened 
beverages, and fruit juice were not significantly asso-
ciated with type 2 diabetes in studies recruiting more 
men than women or conducted in Asia, with a fewer 
number of studies than in the main analysis (supple-
mentary table S5).
Publication bias was not evident by Egger’s test 
(P>0.05), except for fruit juice (P=0.03), where esti-
mates with the greater precision showed stronger asso-
ciations (fig 2). Trim and fill indicated publication bias 
for both sugar sweetened and artificially sweetened 
beverages (table 2). In particular, publication bias 
could influence inference for artificially sweetened 
beverages. With adjustment for adiposity, the relative 
risk per one serving/day of artificially sweetened bev-
erages was 1.29 (1.08 to 1.54) before calibration for 
publication bias and 1.22 (0.98 to 1.52) after calibration 
(table 2).
Contour enhanced funnel plots indicated that the 
findings for artificially sweetened beverages and fruit 
juice were not stable (fig 2). For example, if a study with 
a relative risk of 0.5 contributed to the meta-analysis, 
associations of artificially sweetened beverages and 
fruit juice with type 2 diabetes incidence would not be 
significant. In influence analysis, positive associations 
persisted for sugar sweetened beverages and artificially 
sweetened beverages (see supplementary figure S3), 
whereas a significant result of fruit juice was not seen 
after excluding any single studies supporting the posi-
tive association.
The results varied little by methodological assump-
tion (see supplementary table S6), using estimates per 
250 mL/day (median of 17 studies) rather than per 
serving/day; excluding studies with a high risk of 
potential bias or with relatively large within person 
dietary variability; and incorporating uncertainty of 
within person variability and precision of type 2 diabe-
tes diagnosis. When we examined the potential influ-
ence of residual confounding by measured adiposity, 
bias towards the null appeared substantial for artifi-
cially sweetened beverages (see supplementary figure 
S4). Under a realistic assumption of a correlation of 
0.80 between measured and true adiposity,36 the asso-
ciation for sugar sweetened beverages was attenuated 
by 26% (relative risk 1.20, 1.04 to 1.38), for artificially 
sweetened beverages was attenuated by 96% (1.01, 
0.81 to 1.25), and for fruit juice was strengthened by 
19% (1.12, 1.03 to 1.22).
table 2 | associations between consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit 
juice and incident type 2 diabetes: meta-analysis of prospective cohort studies
beverages (no of cohorts) and models of 
meta-analysis*
not adjusted for adiposity† adjusted for adiposity†
relative risk (95% Ci) i2 (%) relative risk (95% Ci) i2 (%)
sugar sweetened beverages (n=17)
Meta-analysis, crude: 1.25 (1.14 to 1.37) 89 — —
 +multivariable adjusted 1.18 (1.09 to 1.28) 89 1.13 (1.06 to 1.21) 79
  +calibration for information bias 1.43 (1.20 to 1.70) 86 1.28 (1.12 to 1.46) 73
   +calibration for publication bias 1.42 (1.19 to 1.69) 85 1.27 (1.10 to 1.46) 73
artificially sweetened beverages (n=10)
Meta-analysis, crude: 1.48 (1.35 to 1.62) 85 — —
 +multivariable adjusted 1.25 (1.18 to 1.33) 70 1.08 (1.02 to 1.15) 64
  +calibration for information bias 2.13 (1.57 to 2.88) 72 1.29 (1.08 to 1.54) 50
   +calibration for publication bias 1.81 (1.33 to 2.47) 76 1.22 (0.98 to 1.52) 64
Fruit juices (n=13)
Meta-analysis, crude: 0.97 (0.90 to 1.06) 79 —
 +multivariable adjusted 1.05 (0.99 to 1.11) 58 1.07 (1.01 to 1.14) 51
  +calibration for information bias 1.06 (0.98 to 1.14) 49 1.10 (1.01 to 1.20) 29
   +calibration for publication bias Not detected — Not detected —
*Number of cohorts varied slightly by models (see fig 1). Crude meta-analysis pooled estimates without any adjustment. Multivariable adjusted 
estimates were based on meta-analysis of estimates adjusted for demographic and lifestyle covariates (see supplementary table S4 for details). 
Calibration for information bias accounted for within person variation for dietary consumption and imprecise ascertainment of self reported diabetes. 
Calibration for publication bias was carried out, if indicated in trim and fill analysis. 
†Relative risk and 95% confidence intervals per serving/day before and after adjustment for adiposity. All relative risks were significant (P<0.05), except 
for artificially sweetened beverages after adjustment for publication bias (P=0.07).
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We rated the quality of evidence for sugar sweetened 
beverages, artificially sweetened beverages, and fruit 
juice. The evidence for sugar sweetened beverages was 
rated as being of moderate quality. The main finding 
rejected the null hypothesis and was likely to have a 
small degree of heterogeneity unexplained, a dose-re-
sponse relation, and robustness against potential bias 
or limitations including publication bias. We rated the 
evidence for artificially sweetened beverages and fruit 
juice to be of low quality. Findings for artificially sweet-
ened beverages were likely to have publication bias 
and residual confounding; and for fruit juice, the posi-
tive association was not stable and varied by study 
design.
Sugar sweetened beverages
  EPIC-InterAct11
  ARIC64
  Black WHS58
  NHS II41 60 61
  KIHD54
  NHS I41 51
  CARDIA55 56
  HPFS41 49 50
  FOS65
  Iowa WHS62
  MESA39
  Occupation cohort, Japan59
  SCHS57
  HIPOP-OHP63
  E3N40
  JPHC52
  FMCHES53
Overall
Articially sweetened beverages
  EPIC-InterAct11
  NHS II41 60 61
  NHS I41 51
  MESA39
  HPFS41 49 50
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  CARDIA55 56
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  Occupation cohort, Japan59
  E3N40
Overall
Fruit juice
  NHS I41 51
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  FOS65
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  CARDIA55 56
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Fig 1 | Prospective associations of beverage consumption with incident type 2 diabetes: random effects meta-analysis. *unadjusted for adiposity. 
†adjusted for adiposity. ‡adjusted for adiposity and within person variation. Cohorts were ordered by weights in the most adjusted model. estimates 
with 95% confidence intervals greater than 10 are not presented. supplementary table s4 summarises the covariates adjusted for in each study
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type 2 diabetes risk attributable to sugar 
sweetened beverages
Overall, sugar sweetened beverages were consumed by 
54.4% of people in the USA and 49.4% in the UK. Of a 
total population, the mean consumption of sugar 
sweetened beverages was 284 (SD 412) g/day in the USA 
and 114 (SD 157) g/day in the UK (fig 3 and supplemen-
tary table S7). Absolute event rates over 10 years from 
2010 were estimated to be 11.0% in the USA (20.9 mil-
lion events) and 5.8% in the UK (2.6 million events). 
Assuming a causal effect of consumption of sugar 
sweetened beverages partly mediated by obesity status 
(adiposity unadjusted), consumption in the USA would 
result in 2.6 million excess events of type 2 diabetes over 
10 years (population attributable fraction 11.9%, 95% 
confidence interval 7.4% to 16.5%); and 126 000 excess 
events in the UK (population attributable fraction 4.9%, 
3.0% to 7.2%). Assuming a causal effect of consumption 
of sugar sweetened beverages independent of obesity 
status (adiposity adjusted), consumption would result 
in 1.8 million excess events in the USA (population 
attributable fraction 8.7%, 3.9% to 12.9%) and 79 000 
excess events in the UK (population attributable frac-
tion 3.6%, 1.7% to 5.6%). Younger adults and men would 
have greater numbers of type 2 diabetes events related 
to consumption of sugar sweetened beverages than 
older adults and women, respectively (fig 3 and supple-
mentary table S7). The greater the uncertainty 
accounted for, the lesser the precision was computed 
(see supplementary figure S5). For example, if I2=50%, 
the population attributable fraction of 11.9% in the USA 
would have a 95% confidence interval of 5.2% to 18.3%, 
but remained significant from 0 for the relative risks we 
estimated. 
discussion
In this systematic review and meta-analysis, we have 
produced summary evidence that habitual consump-
tion of sugar sweetened beverages, artificially sweet-
ened beverages, and fruit juice was prospectively 
associated with incident type 2 diabetes, independently 
of adiposity. Sensitivity analyses consistently sup-
ported the positive association of sugar sweetened bev-
erages with incident type 2 diabetes. In contrast, the 
association between artificially sweetened beverages or 
fruit juice and incident type 2 diabetes was less evident. 
For artificially sweetened beverages, potential publica-
tion bias and residual confounding were likely to exist. 
For fruit juice, the finding seemed to be unstable and 
was sensitive to study design. Under assumption of cau-
sality for the association of consumption of sugar 
sweetened beverages with incidence of type 2 diabetes, 
we provided efficacy estimates that over 10 years two 
million type 2 diabetes events in the USA and 80 000 in 
the UK would be related to consumption of sugar sweet-
ened beverages.
strengths and limitations of this review
This study has limitations typical of observational stud-
ies and meta-analysis. Residual confounding could 
exist.37 Confounding by socioeconomic and dietary 
 factors was not detected to be strong in published stud-
ies. However, measures of these variables were likely to 
involve errors such that residual confounding persisted 
in individual studies and our meta-analysis. Addition-
ally, lifestyle factors and adiposity could change over 
time. The time varying characteristics might not be ran-
dom and could result in bias in an unknown direction. 
Reverse causality could also exist because of unmea-
sured comorbid conditions and health consciousness 
that might alter consumption of beverages, particularly 
artificially sweetened ones, and risk of type 2 diabetes. 
Weakness of meta-analysis includes the exclusion of 
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Fig 2 | Funnel plot for associations of sugar sweetened 
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eligible cohorts for lack of information. Our meta- analysis 
included statistical approximation that might involve 
errors. For example, we derived dose-response esti-
mates partly from categorical estimates and odds ratios. 
Without such approximations, analysis standardised 
across different cohorts is of future interest to character-
ise associations between various beverages and risks of 
type 2 diabetes. Finally, assessments of bias and quality 
of evidence involved subjectivity, although we objec-
tively examined the influence of potential bias in tests 
for heterogeneity and sensitivity analyses.
One strength of this study was in estimating popula-
tion attributable fraction for risks of type 2 diabetes 
related to consumption of sugar sweetened beverages in 
the USA and UK, using data on beverage consumption 
for each individual. While a few studies estimated how 
much taxation on sugar sweetened beverages influ-
enced risk of obesity and type 2 diabetes,12-14  no study 
examined the population impact by combining esti-
mates for consumption of sugar sweetened beverages in 
multiple populations, predicted the risk of type 2 diabe-
tes by using a validated algorithm, or provided quanti-
tative evidence on the association of consumption of 
sugar sweetened beverages with incidence of type 2 
diabetes. However, the population attributable fraction 
was limited in precision owing to underlying relative 
risks and uncertainty in generalisability. The other lim-
itations are that we estimated the population attribut-
able fraction under the assumption of causality, 
although it has not been established; and the assump-
tion that there would be no change over time in lifestyle 
associated with consumption of sugar sweetened bever-
ages. Future work should seek to improve precision of 
evidence and to characterise efficacy and effectiveness 
of policy interventions for different populations. Gener-
alisability should be explored—for example, for popu-
lations in Central and South America with the highest 
recorded per capita sales of sugar sweetened beverages 
in the world; and China and India where the highest 
prevalence of type 2 diabetes is expected.1 67 To mini-
mise limitations typical of observational research and 
understand effectiveness of a policy intervention in dif-
ferent populations, future research should also include 
randomised trials examining people’s health and 
behaviours and informing effectiveness.
interpretation in relation to other studies
Other quantitative reviews have been published 
recently.4 5 9  None of them quantified the population 
attributable fraction. One meta-analysis evaluated the 
influence of adiposity on the association of sugar sweet-
ened beverages and type 2 diabetes based on three stud-
ies, but not artificially sweetened beverages or fruit 
juice.5 For sugar sweetened beverages, we evaluated a 
greater number of type 2 diabetes cases (38 285 v 19 054) 
and studies (17 v 3), including bias assessments and 
sensitivity analyses. For fruit juice and artificially 
sweetened beverages, we evaluated a greater number of 
studies than previous work (9 v 4 and 12 v 4, respec-
tively) and drew conclusions based on assessment of 
the influences of adiposity and potential bias that were 
found to be important.
The plausibility of our findings deserves discussion. 
Detrimental effects of sugar sweetened beverages inde-
pendent of obesity may exist. Sugars in sugar sweet-
ened beverages acutely increased blood glucose levels 
and have a high glycaemic index (80 to 110/100 of white 
bread), a risk factor for type 2 diabetes.68 69  Fructose in 
sugar sweetened beverages promotes hepatic lipogene-
sis and further insulin resistance.2  Effects of caramels 
for colouring beverages,70  caffeine,49 71  phosphoric 
acid,72 and other constituents may also exist. These 
non-glycaemic effects may be present in artificially 
sweetened beverages, if such beverages truly increase 
the risk of type 2 diabetes. Artificially sweetened bever-
ages might have effects on hormones, microbiota, and 
taste preference, but evidence for these remains 
weak.6  73 74  Adverse effects of fruit juice would be 
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 present because of its moderately high glycaemic index 
(50-80).68  Healthful constituents may exist but decrease 
during processing.7 75  This explains why our finding 
was discordant with the inverse association of consum-
ing fruits as food with type 2 diabetes.76
Our analysis indicated possible publication bias for 
the associations between artificially sweetened bever-
ages and type 2 diabetes. The bias toward a false posi-
tive finding would be plausible according to existing 
public interest over the health effects.6  77  The finding at 
least underscores potential low quality of evidence and 
the need for cautious interpretation. Residual 
 confounding in the finding for artificially sweetened 
beverages is also plausible because adults at high risk 
of type 2 diabetes preferentially consumed more artifi-
cially sweetened beverages.5 6 8 10 11 36  Confounding in 
the opposite direction in the finding for fruit juice is 
also plausible because leaner adults at lower risk of 
type 2 diabetes consumed more fruit juice.10 11  These 
observations provide research and clinical implications 
for better understanding of health seeking behaviours 
related to beverage consumption.6 78
Clinical and public health implications
Although causality has not been established, our find-
ings and available evidence indicate a benefit of reduc-
ing the consumption of sugar sweetened beverages for 
the primary prevention of type 2 diabetes. In the same 
context, our findings also imply that consumption of 
artificially sweetened beverages or fruit juice is not 
likely to reduce the risk of type 2 diabetes and, thus, not 
suitable as a healthy option. None the less, the lower 
caloric intake of artificially sweetened beverages may 
be of clinical benefit in obese or overweight adults by 
helping to reduce body weight.6 78 This effect on body 
weight should be considered separately from our study, 
which could not rule out the effect of body weight on 
beverage consumption.8  Additionally, clinical applica-
tions of our finding deserve further appraisal about the 
effects of altering beverage consumption on changes in 
lifestyle behaviours and on risks of other clinical 
 outcomes.3 6 8
Our findings have strong public health implications. 
Despite the limitations of this review, the current con-
sumption of sugar sweetened beverages was estimated 
to cause approximately two million excess events of 
type 2 diabetes in the USA and 80 000 in the UK over 10 
years. This could cost nearly £12.0bn in the USA and 
£206m in the UK ($9800 in the USA and $3994 in the UK 
per patient,67  $1 (£0.65; €0.91 as of 7 July 2015). In 
future, our work on efficacy should be extended to that 
on effectiveness to identify needs for interventions. In 
addition to observational evidence, trial evidence 
should be available, accounting for the effects on car-
diometabolic health and lifestyle change associated 
with a possible intervention.8 78 Despite a population 
attributable fraction of no more than 20%, effectiveness 
should be evaluated for different populations, as an 
estimated 592 million adults globally will have type 2 
diabetes in 2035.1 67  Additionally, the average popula-
tion attributable fraction of no more than 20% confirms 
the importance of modifying multiple lifestyle risk fac-
tors rather than a single dietary component, for the pri-
mary prevention of type 2 diabetes. For artificially 
sweetened beverages and fruit juice, our findings 
inform little benefit of using them as an alternative to 
sugar sweetened beverages. In addition, fruit juice con-
sumption should not be a part of dietary recommenda-
tions for greater consumption of fruits and vegetables, 
as suggested to limit fruit juice consumption among 
children.7  79
Conclusions
Observational cohort studies support that consumption 
of sugar sweetened beverages is associated with inci-
dent type 2 diabetes, and independently of adiposity. 
This finding was stable in sensitivity analyses assessing 
influence of population characteristics, potential resid-
ual confounding, and publication bias. By contrast, 
although artificially sweetened beverages and fruit 
juice showed a positive association with incident type 2 
diabetes, the quality of evidence is limited by potential 
bias and heterogeneity by study design. Although cau-
sality has not been established and precision needs to 
be improved, this study informs the potential efficacy of 
reducing the consumption of sugar sweetened bever-
ages in a contemporary population. Moreover, findings 
support that neither artificially sweetened beverages 
nor fruit juice are suitable alternatives to sugar sweet-
ened beverages for the prevention of type 2 diabetes. 
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